Clinical Trials
253 trials177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
National Institutes of Health Clinical Center (CC)
SCREEN-HPV
UNICANCER
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Treatment of Recurrent/Metastatic Head and Neck Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
InduPro, Inc.
A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal Carcinoma
Guangzhou Concord Cancer Center
GATEWAY
Sun Yat-sen University
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
Lepu Biopharma Co., Ltd.
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
Corregene Biotechnology Co., Ltd
Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors
West China Hospital
HOPES
Centre Leon Berard
Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
University of Oklahoma
NEO COMBAT XL
UNC Lineberger Comprehensive Cancer Center
Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate
Sun Yat-sen University
Evaluating Avive+ Soft Tissue Matrix for Prevention of Superficial Radial Nerve Morbidity Following Radial Forearm Free Flap Harvest
University of Alabama at Birmingham
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Fred Hutchinson Cancer Center
ABY-029 Head & Neck Trial
Dartmouth-Hitchcock Medical Center
PRO-COMAND
University of Pisa
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
Sun Yat-sen University
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
NRG Oncology
AK112
National University Hospital, Singapore
SNIFF
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PREPACHIR ORL
Centre Henri Becquerel
NimoBenSeq
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
RAIN-HNSCC
Sun Yat-sen University
Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Mayo Clinic
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Washington University School of Medicine
EPoRN
Jiangxi Provincial Cancer Hospital
Effectiveness of 0.9% Normal Saline Soaking in Managing Acute Radiation Dermatitis
King Hussein Cancer Center
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.
Sun Yat-sen University
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC)
Shanghai Zhongshan Hospital
Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma
Tang-Du Hospital
A Phase II Prospective, Open-Label, Randomized, Multicenter Study of Kangfu Spray for the Prevention of Radiation-Induced Oral Mucositis in Patients With Oral Malignancies Receiving Intensity-Modulated Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Decision Aid Efficacy in Low Risk Thyroid Cancer
University of Maryland, Baltimore
Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer
National Cancer Institute, Egypt
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
M.D. Anderson Cancer Center
REPOTHYROID-II
Radboud University Medical Center
C-Head-002
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
University of Michigan Rogel Cancer Center
N'FORCE
Groupe Oncologie Radiotherapie Tete et Cou
STRAP
National Cancer Centre, Singapore
Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
preReDSeL
Centre Hospitalier Universitaire Vaudois
THYMAL 01
Sound Blade Medical Inc.
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Dana-Farber Cancer Institute
NOCANO
Karolinska University Hospital
Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC
Fudan University